• Mashup Score: 0

    Hear from healthcare innovators about how the intersections of technology and innovation, health equity, community partnerships, and value-based care that can elevate humanity from the cradle to encore careers to create the future of health. Check back for more on the Elevating Kids Health program in the next few weeks.

    Tweet Tweets with this article
    • I’m thrilled to be part of @Nemours #pediatric track at @HLTHEVENT this year! Join me next week for my panel, An Introduction to the Technology & Human Aspects of the “New” Children’s Healthcare on 10/8 at 10:35 am PDT. More ➡️ https://t.co/uYz1eeKxXQ #HLTHxNemours #HLTH2023 https://t.co/TdrgVfC13B

  • Mashup Score: 0

    In this edition of The Journal of Rheumatology , I will be bringing to your attention the following 6 articles from the 2010s that had, and continue to have, a significant impact in rheumatology. Although I usually choose 3 papers, I have chosen 6 that can be grouped into 3 categories. The first category has a single paper that describes a modification of the American College of Rheumatology (ACR) classification of fibromyalgia (FM),1 the second category contains 2 papers on the use of the internet and social media in rheumatology,2,3 and the third contains 3 papers on long-term outcome studies in rheumatoid arthritis (RA).4-6 The first paper I wish to bring to your attention is “Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia” by Wolfe et al. … Address correspondence to Dr. E.D. Silverman, Editor-in-Chief, The Journal of Rheumatology, 365 Bloor Street East, Suite 901, Toronto

    Tweet Tweets with this article
    • Editorial 50th Year of Publication: Progress in Rheumatology During the 2010s 📰 https://t.co/fjnqaYPcqT #rheumatoidarthritis #fibromyalgia #pediatric #jrheum50 #publishing #rheumatology https://t.co/GDgHQGaMQN

  • Mashup Score: 0

    I am very much enjoying your trip down memory lane looking back at important articles in The Journal of Rheumatology . I was especially interested in your “Looking Back at the 1990s.” I would like to point out an important milestone in The Journal that also took place in the 1990s, that is, the establishment of Pediatric Rheumatology as a section in The Journal .

    Tweet Tweets with this article
    • @jrheum was the first journal to offer a publication dedicated to topics in pediatric rheumatology and continues to publish important research in this area. 📰 https://t.co/2Jiq4XuUAg #PReS2023 #pediatric #rheumatology https://t.co/v9T1CiaTKF

  • Mashup Score: 0

    Open comment allows for key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication.

    Tweet Tweets with this article
    • We’re accepting comments on our draft guideline re: antineoplastic therapy administration safety standards for adult and #pediatric oncology. Submit feedback by October 18: https://t.co/nKRBrmtgUH https://t.co/JnGcvYmVT6

  • Mashup Score: 0

    To the Editor: Juvenile systemic sclerosis (jSSc) is a rare but potentially life-threatening disease, with a prevalence of 3 to 4 in 1,000,000 children. Similar to that in adults,1 interstitial lung disease (ILD) is the major cause of morbidity in children with systemic sclerosis (SSc) and occurs at similar prevalences.2 The rarity of jSSc has made large-scale studies challenging; thus, much of jSSc-ILD care is extrapolated from adult recommendations. Adult SSc-ILD clinical studies have demonstrated that early detection3 and careful monitoring of ILD, including responsiveness to immunosuppressive therapies, is critical to improve pulmonary outcomes. As such, there is a great need to develop jSSc-specific guidelines for ILD, which will require large, multinational cohorts with standardization of detection and monitoring techniques. Currently, detection of ILD is typically made by a combination of high-resolution chest computed tomography (HRCT) and pulmonary function tests (PFTs). Where

    Tweet Tweets with this article
    • Research Letter on Pediatric Rheumatology from our September issue. 📰 https://t.co/Hvqfp7Z3Pw Here is the Table of Contents. 📰 https://t.co/5XnwDisxrh #PReS2023 #pediatric #juvenilesystemicsclerosis #rheumatology https://t.co/uBWULMI1Em

  • Mashup Score: 1

    Objective To test the association of early disease severity with grade 12 standards test performance in individuals with childhood-onset chronic rheumatic diseases (ChildCRDs), including juvenile arthritis and systemic autoimmune rheumatic diseases. Methods We used linked provincial administrative data to identify patients with ChildCRDs born between 1979 and 1998 in Manitoba, Canada. Primary outcomes were Language and Arts Achievement Index (LAI) scores and Math Achievement Index (MAI) scores from grade 12 standards test results as well as enrollment data. The secondary outcome was enrollment in grade 12 by 17 years of age. Latent class trajectory analysis identified disease severity groups using physician visits following diagnosis. Multivariable linear regression tested the association of disease severity groups with LAI and MAI scores, and logistic regression tested the association of disease severity with age-appropriate enrollment, after adjusting for sociodemographic factors and

    Tweet Tweets with this article
    • Have a look at our Pediatric Rheumatology papers from our September issue. 📰 https://t.co/TVfk14FTtj 📰 https://t.co/9ak8wATXXh #PReS2023 #pediatric #rheumatology https://t.co/sfUeIL7NUN